Lam Research
LRCX
$323.86
+2.99%
Lam Research is one of the world's largest semiconductor wafer fabrication equipment manufacturers, specializing in deposition and etch processes that build up and selectively remove layers on semiconductor wafers, serving memory and logic chipmakers including TSMC, Samsung, Intel, and Micron. The company holds the top market share in etch and the clear second position in deposition, making it a critical enabler of advanced chip manufacturing rather than a commodity supplier. The current investor narrative centers on Lam's pivotal role in the AI infrastructure build-out, with recent headlines debating whether the company could become the next $1 trillion enterprise and highlighting record quarterly revenue driven by AI-related demand. At the same time, the stock has become a battleground between momentum investors emboldened by a 146% one-year gain and valuation skeptics who note a sharp 16.9% three-month pullback and a beta of 1.86 that amplifies both rallies and selloffs.…
LRCX
Lam Research
$323.86
Related headlines
Investment Opinion: Should I buy LRCX Today?
The synthesized recommendation is a Hold with a bullish bias, reflecting the strong fundamental momentum and analyst consensus offset by stretched valuation and weak near-term technicals. The core thesis is that Lam Research is a structural beneficiary of the AI infrastructure build-out, with revenue growing 23.76% YoY and margins expanding, but the stock's trailing PE of 70.97x and PS ratio of 22.20x already price in much of the good news. The analyst consensus is a strong buy with a recommendation mean of 1.46 and an average target of $373.77, implying 18.6% upside, but the average target sits below the 52-week high of $438.50, suggesting limited room for multiple expansion.
The supporting evidence for a constructive view includes: (1) revenue re-acceleration to $5.841B in the latest quarter, up 23.76% YoY, with six consecutive sequential increases; (2) net margin expansion to 31.25% from 28.19% a year ago, demonstrating operating leverage; (3) robust free cash flow of $6.451B on a trailing basis, funding $1.163B of buybacks and $326M of dividends; (4) a strong balance sheet with debt-to-equity of 0.33 and current ratio of 2.63; and (5) a strong buy consensus from 31 analysts with no recent downgrades. However, the forward PE of 26.85x is at the upper end of the historical range, and the PEG ratio of 1.83 indicates the stock is not cheap on a growth-adjusted basis.
The biggest risks that could invalidate the thesis are: (1) a slowdown in AI-driven capex or memory spending, which could cause revenue growth to decelerate below 10% and trigger multiple compression; (2) margin compression if competition intensifies or if the mix shifts toward lower-margin systems; and (3) a broader market correction given the 1.86 beta, which could push the stock below the $250 support level. The rating would upgrade to Buy if the stock pulls back to the $250-$270 support zone or if forward PE compresses below 20x, and it would downgrade to Sell if revenue growth decelerates below 10% or if gross margin falls below 45%. Relative to its history and peers, the stock appears fairly valued to slightly overvalued, with the market pricing in highly optimistic expectations for AI-driven growth.
Sign up to view all
LRCX 12-Month Price Forecast
Lam Research presents a compelling fundamental story with accelerating revenue growth, expanding margins, and a fortress balance sheet, but the valuation already reflects much of the AI-driven optimism. The stock's 16.85% three-month decline and -22.66% relative strength versus SPY suggest near-term momentum has broken, even as the long-term trend remains intact. The wide analyst target range of $290 to $500, combined with the 1.86 beta, indicates high uncertainty and suggests a neutral stance with a bullish bias for long-term investors. I would upgrade to bullish if the stock pulls back to the $250-$270 support zone or if forward PE compresses below 22x, and downgrade to bearish if revenue growth decelerates below 10% or if gross margin falls below 47%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $373.77 and implied upside of +15.4% versus the current price.
Average Target
$373.77
0 analysts
Implied Upside
+15.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$290 - $500
Analyst target range
Lam Research is covered by 31 analysts, and the consensus recommendation is a strong buy with a recommendation mean of 1.46 (where 1.0 is a strong buy and 5.0 is a sell). The average price target is $373.77, which implies approximately 18.6% upside from the current price of $315.21. The consensus leans clearly bullish, supported by a steady stream of Buy and Overweight ratings from major firms including Needham, Stifel, Mizuho, TD Cowen, Morgan Stanley, Susquehanna, Cantor Fitzgerald, B of A Securities, Wells Fargo, and Citigroup, all of which reiterated positive ratings between June and July 2026 with no downgrades in the visible institutional ratings data. The full target range spans from a low of $290.00 to a high of $500.00, a spread of $210 or roughly 72% of the current price, which signals meaningful disagreement about the magnitude of the AI-driven earnings ramp. The high target of $500 implies roughly 59% upside and assumes continued multiple expansion alongside accelerating revenue growth toward the analyst consensus estimate of $55.75 billion (with a high estimate of $62.27 billion), while the low target of $290 implies about 8% downside and likely prices in margin compression, a memory capex slowdown, or cyclical normalization. The wide spread, combined with the stock's 1.86 beta and -41.76% max drawdown, indicates high uncertainty and suggests investors should size positions accordingly; the absence of any recent downgrades is a positive signal, but the fact that the average target sits below the 52-week high of $438.50 implies analysts see the stock as fairly valued after its massive run rather than deeply undervalued.
Bulls vs Bears: LRCX Investment Factors
The bull case currently has stronger evidence, anchored by accelerating revenue growth of 23.76% YoY, expanding margins, a fortress balance sheet, and a strong buy consensus from 31 analysts with an 18.6% average upside target. However, the bear case is not without merit: the trailing PE of 70.97x is far above historical norms, the stock has broken down 16.85% over three months, and the 1.86 beta amplifies downside in any market correction. The single most important tension is whether the AI-driven capex cycle can sustain the earnings ramp implied by the forward PE of 26.85x and the analyst EPS estimate of $17.30; if it does, the stock is reasonably valued and could reach $500, but if AI spending decelerates or memory capex slows, the multiple could compress sharply toward the $290 low target or the $250 support zone. Near-term technicals are weak, but the long-term trend remains intact, making this a high-conviction but high-volatility name that requires careful position sizing.
Bullish
- Revenue re-acceleration is powerful: Latest quarter revenue of $5.841B grew 23.76% YoY, the strongest growth in the visible multi-quarter trend, and marked the sixth consecutive sequential increase from $4.168B in Q1 FY2025. This acceleration is driven by AI-related demand for Lam's deposition and etch tools, suggesting the company is in the early-to-mid innings of a structural capex cycle rather than a cyclical peak.
- Margins expanding with operating leverage: Net margin expanded to 31.25% in the latest quarter from 28.19% a year ago, while operating margin rose to 35.04% from 33.09% and gross margin improved to 49.83% from 49.02%. The sequential net margin progression from 29.46% to 29.82% to 31.25% over the last three quarters demonstrates that incremental revenue is dropping through to the bottom line at a high rate.
- Fortress balance sheet and cash generation: Debt-to-equity is a conservative 0.33, current ratio is 2.63, and ROE is an exceptional 58.26% with ROA of 22.84%. Trailing free cash flow is $6.451B, and the latest quarter generated $1.141B in operating cash flow against just $332M of capex, funding $1.163B of buybacks and $326M of dividends without external financing.
- Analyst consensus strongly bullish: 31 analysts rate the stock a strong buy with a recommendation mean of 1.46, and the average price target of $373.77 implies 18.6% upside from $315.21. The high target of $500 implies 59% upside, and there have been no downgrades in the visible institutional ratings data between June and July 2026.
Bearish
- Valuation leaves no room for error: The trailing PE of 70.97x is far above the historical range of roughly 9x to 34x, and the PS ratio of 22.20x and PB ratio of 41.35x are near or above multi-year highs. Even the forward PE of 26.85x is at the upper end of the historical band, and the PEG ratio of 1.83 indicates the stock is not cheap on a growth-adjusted basis.
- Severe near-term momentum breakdown: The stock is down 16.85% over three months and just 0.74% over one month, a sharp reversal from the 49.1% six-month gain and 146.0% one-year gain. Relative strength versus SPY has collapsed to -22.66% over three months, signaling that institutional money is rotating out of the name despite the strong long-term trend.
- High beta amplifies downside risk: With a beta of 1.859, the stock is roughly 86% more volatile than the S&P 500, and the maximum drawdown over the period was -41.76%. This means a market correction or a sector rotation could disproportionately punish LRCX, and position sizing must be materially smaller than for a market-average equity.
- Analyst targets imply limited upside: The average target of $373.77 is below the 52-week high of $438.50, suggesting analysts see the stock as fairly valued after its massive run rather than deeply undervalued. The low target of $290 implies about 8% downside, and the wide $210 spread between high and low targets signals significant disagreement about the magnitude of the AI-driven earnings ramp.
LRCX Technical Analysis
Lam Research is in a powerful longer-term uptrend that has recently entered a corrective phase. The stock is up 146.0% over the past year and 70.3% year-to-date, yet at $315.21 it sits only about 60% of the way up its 52-week range of $126.37 to $438.50, roughly 28% below the high. That positioning suggests the stock is neither at euphoric highs nor at distressed lows, but in a wide, volatile consolidation zone where the long-term trend remains intact while short-term conviction has weakened. Recent momentum is clearly decelerating: the 1-month change is just +0.74% and the 3-month change is -16.85%, a sharp reversal from the +49.1% six-month gain. This divergence between a strong 1-year trend and a negative 3-month trend signals a meaningful mean-reversion phase, likely a digestion of the parabolic April-to-June advance that peaked near $438. The stock's relative strength versus SPY has collapsed to -22.7% over three months even as it remains +128.8% over one year, confirming that near-term money is rotating out of the name. Key technical levels are well defined: the 52-week low at $126.37 is the ultimate support, with intermediate support around the $250-$270 area where the stock found buyers in late July and mid-September, while resistance sits at the $438.50 high with a nearer ceiling near $340-$360 where rallies have repeatedly stalled. A breakout above $360 would suggest the correction is over and the uptrend is resuming, whereas a breakdown below $270 would threaten the medium-term structure and open the door toward $250. With a beta of 1.859, the stock is roughly 86% more volatile than the S&P 500, meaning position sizing should be materially smaller than for a market-average equity, and a max drawdown of -41.76% over the period underscores the severity of the risk.
Beta
1.86
1.86x market volatility
Max Drawdown
-41.8%
Largest decline past year
52-Week Range
$131-$439
Price range past year
Annual Return
+147.1%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | +7.3% | -0.7% |
| 3m | -17.2% | +2.5% |
| 6m | +48.3% | +16.5% |
| 1y | +147.1% | +15.2% |
| ytd | +75.0% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam Research's revenue trajectory is strongly re-accelerating, with the most recent quarter (ending 2026-03-29) delivering $5.841 billion in revenue, up 23.76% year-over-year from $4.720 billion in the year-ago quarter. The multi-quarter trend is unambiguous: revenue climbed from $4.168 billion in Q1 FY2025 to $4.376 billion, $4.720 billion, $5.172 billion, $5.324 billion, $5.345 billion, and finally $5.841 billion in the latest quarter, marking a steady sequential cadence with the largest jump in the most recent period. Segment data shows Systems revenue of $3.731 billion and Customer Support and Other revenue of $2.111 billion, indicating that both new equipment sales and the recurring, higher-margin installed-base business are contributing meaningfully. This accelerating top line, driven by AI-related demand for advanced deposition and etch tools, supports the bull case that Lam is a structural beneficiary of the multi-year AI infrastructure build-out rather than a cyclical peak story. Profitability is robust and expanding: net income in the latest quarter was $1.825 billion on a 31.25% net margin, up from $1.331 billion and a 28.19% net margin in the year-ago quarter. Gross margin stands at 49.83% in the latest quarter, up from 49.02% a year earlier, while operating margin has expanded to 35.04% from 33.09%, and EBITDA margin is a healthy 37.10%. The company is solidly profitable with a 50.47% gross margin and 35.29% operating margin on a trailing basis, and the sequential improvement in net margin from 29.46% to 29.82% to 31.25% over the last three quarters demonstrates operating leverage as revenue scales. The balance sheet and cash flow profile are strong: debt-to-equity is a conservative 0.33, the current ratio is 2.63, and ROE is an exceptional 58.26% with ROA of 22.84%. Free cash flow on a trailing twelve-month basis is $6.451 billion, and the company generated $1.141 billion in operating cash flow in the latest quarter against $332 million of capex, funding $1.163 billion of stock repurchases and $326 million of dividends. With $4.767 billion of cash on hand and net cash from financing of -$2.231 billion reflecting aggressive capital returns, Lam is self-funding its growth and returning substantial capital to shareholders without reliance on external financing.
Quarterly Revenue
$5.8B
2026-03
Revenue YoY Growth
+23.8%
YoY Comparison
Gross Margin
49.8%
Latest Quarter
Free Cash Flow
$6.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Because Lam Research is solidly profitable with positive net income of $1.825 billion in the latest quarter, the PE ratio is the appropriate primary valuation metric. The trailing PE stands at 70.97x, while the forward PE is 26.85x, an enormous gap that implies the market expects earnings to roughly 2.6x over the next year, consistent with the analyst consensus EPS estimate of $17.30 versus the current trailing EPS of $0.014 (which appears distorted by a data anomaly). The forward PE of 26.85x is the more economically meaningful figure and suggests the market is pricing in strong earnings growth driven by the AI capex cycle. Relative to the broader semiconductor sector, Lam's forward PE of 26.85x is a moderate premium, and its PS ratio of 22.20x and EV/Sales of 16.48x are elevated, reflecting the market's willingness to pay up for AI-exposed equipment makers. The PEG ratio of 1.83 is above 1.0, indicating the stock is not cheap on a growth-adjusted basis, while the EV/EBITDA of 59.08x and price-to-free-cash-flow of 88.04x are rich, suggesting investors are capitalizing a cyclical peak in cash generation. The premium is partially justified by Lam's dominant etch share, 50.47% gross margin, and 58.26% ROE, but the valuation leaves little room for execution missteps. Historically, Lam's PE ratio has ranged from roughly 9x to 34x over the past several years, and the current trailing PE of 70.97x is far above that band, though the forward PE of 26.85x is closer to the upper end of the historical range. The PS ratio of 22.20x is also near the high end of its historical range (which has spanned roughly 10x to 43x), and the PB ratio of 41.35x is dramatically above the 6x-24x range seen over the past several years. This suggests the market is pricing in highly optimistic expectations, and any deceleration in AI-driven demand or memory capex could trigger a sharp multiple compression given how far the stock has already run.
PE
71.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
59.1x
Enterprise Value Multiple
Investment Risk Disclosure
Lam Research's financial and operational risks are moderate but not negligible. The debt-to-equity ratio of 0.33 and current ratio of 2.63 indicate a conservative balance sheet, and trailing free cash flow of $6.451B comfortably covers the $1.163B of buybacks and $326M of dividends. However, the company's revenue is concentrated in the semiconductor equipment cycle, with significant exposure to memory chipmakers for DRAM and NAND; a memory capex slowdown could cause revenue to contract sharply, as seen in prior cycles. Additionally, the trailing PE of 70.97x and price-to-free-cash-flow of 88.04x suggest the market is capitalizing peak cash generation, leaving little margin for error if margins compress from the current 31.25% net margin or if the 23.76% YoY revenue growth decelerates.
Market and competitive risks are elevated given the stock's 1.86 beta and 41.76% max drawdown. The semiconductor equipment sector is highly cyclical and sensitive to broader tech sentiment; recent news highlights a 'sell the news' reaction to Samsung's strong earnings, signaling potential overvaluation in AI-related sectors. Competition from Applied Materials and Tokyo Electron in deposition and etch could pressure Lam's market share, and any regulatory headwinds around semiconductor exports to China could disrupt revenue. The stock's relative strength versus SPY has collapsed to -22.66% over three months, indicating that near-term money is rotating out of the name, and a sector rotation away from AI infrastructure could trigger further multiple compression.
The worst-case scenario would involve a simultaneous slowdown in AI-driven capex and memory spending, leading to revenue contraction and margin compression. In this scenario, the stock could retest its 52-week low of $126.37, representing a 59.9% decline from the current price of $315.21, or fall to the analyst low target of $290, a 8.0% decline. A more severe outcome, such as a broader market correction given the 1.86 beta, could push the stock below $250, the intermediate support level, implying a 20.7% loss. The maximum drawdown of -41.76% over the period underscores the severity of the risk, and investors should be prepared for a potential 40-60% drawdown in a bear market scenario.
FAQ
The key risks of holding LRCX are ranked by severity as follows: first, valuation compression risk, as the trailing PE of 70.97x and PS ratio of 22.20x leave no room for error, and any deceleration in AI-driven demand could trigger a sharp multiple contraction. Second, cyclical exposure to memory capex, as Lam is more exposed to DRAM and NAND chipmakers, and a memory inventory correction could cause revenue to contract. Third, high volatility risk, with a beta of 1.859 and a max drawdown of -41.76%, meaning the stock could lose 40-60% in a bear market. Fourth, competitive risk from Applied Materials and Tokyo Electron, which could pressure Lam's market share and margins. Additionally, geopolitical risks around semiconductor exports to China could disrupt revenue, and the stock's 3-month relative strength of -22.66% versus SPY indicates near-term institutional selling pressure.
The 12-month forecast for LRCX includes three scenarios: a bull case with 30% probability targeting $438-$500, a base case with 50% probability targeting $340-$400, and a bear case with 20% probability targeting $250-$290. The base case is most likely, assuming revenue growth moderates to the mid-teens but remains above 10%, gross margin holds above 49%, and no major memory capex slowdown occurs. The average analyst target of $373.77 aligns with the base case, implying 18.6% upside from the current price of $315.21. The key assumption behind the base case is that AI infrastructure spending remains robust but does not accelerate further, allowing the stock to consolidate its massive 146% one-year gain. A break above $360 would signal the bull case, while a break below $270 would signal the bear case.
LRCX appears fairly valued to slightly overvalued relative to its own history and peers. The trailing PE of 70.97x is far above the historical range of roughly 9x to 34x, though the forward PE of 26.85x is closer to the upper end of that band. The PS ratio of 22.20x and PB ratio of 41.35x are near or above multi-year highs, and the PEG ratio of 1.83 indicates the stock is not cheap on a growth-adjusted basis. The market is pricing in highly optimistic expectations for AI-driven earnings growth, with the forward PE implying earnings roughly 2.6x over the next year. If the company delivers on the consensus EPS estimate of $17.30, the valuation is justifiable; if growth disappoints, the multiple could compress sharply. Compared to the broader semiconductor sector, LRCX trades at a moderate premium, reflecting its dominant etch market share and 58.26% ROE.
From a risk/reward perspective, LRCX is a good buy for long-term growth investors who can tolerate volatility, but it is not a screaming bargain at current levels. The stock trades at $315.21, with the average analyst target of $373.77 implying 18.6% upside, and the high target of $500 implying 59% upside. However, the trailing PE of 70.97x and PS ratio of 22.20x are elevated, and the 1.86 beta means the stock could easily drop 40% in a market correction, as evidenced by the -41.76% max drawdown. The biggest downside risk is a memory capex slowdown, which could push the stock toward the $250 support or the $126.37 52-week low. For investors with a 3-5 year horizon and a stomach for volatility, LRCX offers exposure to a structural AI growth theme; for short-term traders, the weak 3-month momentum (-16.85%) suggests waiting for a better entry point.
LRCX is more suitable for long-term investment than short-term trading, given its high volatility and cyclical exposure. The stock has a beta of 1.859, a max drawdown of -41.76%, and a 3-month decline of 16.85%, making short-term trading risky without precise timing. The dividend yield is just 0.25%, so income is not a reason to hold. However, the long-term growth story is compelling: revenue is growing at 23.76% YoY, margins are expanding, and the company is a critical enabler of the AI infrastructure build-out. For long-term investors, a minimum holding period of 3-5 years is suggested to ride out the semiconductor cycle and benefit from the structural AI theme. Short-term traders should wait for a breakout above $360 or a pullback to the $250-$270 support zone before entering.